There were more than 48,000 organ transplants in the United States last year. They’re commonplace now, but the practice was considered experimental only a half-century ago.

Everything has to go right for a life-saving transplant. Too often, the system makes it impossible. Sixty-six-year-old Brian ...

Tonix's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer ... Tonix owns and operates a state-of-the art infectious disease research ...

The South Dakota Symphony Orchestra is making a fresh case for Douglas Moore’s “Giants in the Earth,” a Pulitzer ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and re ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

The clumps can damage organs and cause strokes ... Before the modified cells are transplanted, the patient must undergo an intensive chemotherapy treatment to wipe out the bone marrow — where ...

Researchers identified a natural 'brake' within the innate immune system: the inhibitory receptor Siglec-E (SigE) and its human counterparts, Siglec-7 and Siglec-9. This receptor helps prevent ...